Gamco Investors INC. ET AL Buys 17,334 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Gamco Investors INC. ET AL lifted its position in Option Care Health, Inc. (NASDAQ:OPCH) by 18.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,957 shares of the company’s stock after purchasing an additional 17,334 shares during the quarter. Gamco Investors INC. ET AL owned about 0.06% of Option Care Health worth $2,528,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health during the 4th quarter valued at approximately $26,000. UMB Bank n.a. boosted its position in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC grew its holdings in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its position in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Sterling Capital Management LLC raised its stake in Option Care Health by 638.5% during the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company’s stock valued at $69,000 after purchasing an additional 2,554 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Price Performance

OPCH opened at $32.09 on Friday. The business has a fifty day moving average of $33.32 and a 200 day moving average of $28.64. The stock has a market cap of $5.27 billion, a P/E ratio of 26.96, a PEG ratio of 2.30 and a beta of 1.07. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Insider Transactions at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on OPCH. Barrington Research lifted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and boosted their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JMP Securities restated a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.